Development News Edition
Give Feedback
write for Us

Health News Roundup: Salmonella infections; Nursing home safety data; Toddler injuries

Devdiscourse News Desk
Updated: 08-11-2018 11:21 IST
Health News Roundup: Salmonella infections; Nursing home safety data; Toddler injuries

Patients often misunderstand their own odds of experiencing heart disease and its potential consequences, and that means doctors may need to rethink how they explain risk, a new study suggests.

Following is a summary of current health news briefs.

Just $2 per person a year could halt deadly superbugs, OECD says

Halting the rise of deadly drug-resistant "superbug" infections that kill millions around the world could cost just $2 per person a year, the Organisation for Economic Cooperation and Development (OECD) said on Wednesday. Describing drug resistance as "one of the biggest threats to modern medicine", the OECD said, however, that if nothing is done, superbugs could kill some 2.4 million people in Europe, North America and Australia alone over the next 30 years.

Nursing home safety data hard to find

Nursing Home Compare, a web-based tool from the U.S. government that helps consumers look into the quality of nursing homes, falls short when it comes to rating safety, a new study suggests. Nursing Home Compare, on the website, lets users find and compare nursing homes certified by the U.S. Centers for Medicare and Medicaid Services (CMS). ( ) The tool does consider some measures of patient safety, but safety doesn't seem to factor much into the site's rating system and details can be difficult for consumers to dig out, researchers say in a report in Health Affairs.

How doctors describe heart risk can affect patient willingness to act

Patients often misunderstand their own odds of experiencing heart disease and its potential consequences, and that means doctors may need to rethink how they explain risk, a new study suggests. Researchers found that patients were more worried about heart disease and more willing to take preventive medications when told about their long-term, rather than short-term, chances of having problems like heart attack or stroke.

Foamix's treatment for common skin condition meets late-stage trial goals

Foamix Pharmaceuticals Ltd said on Wednesday its experimental foam treatment for rosacea, a common skin condition that causes acne-like bumps and redness on the face, met the main goals of two late-stage clinical trials. The treatment, code-named FMX103 and made up of an antibiotic commonly used to treat infections, significantly reduced inflammatory lesions, compared to a foam without the antibiotic, minocycline.

Israel's Intec Pharma eyes revenue from Parkinson's drug in 2019

Israel's Intec Pharma, which is conducting a late stage trial for its long-lasting pill to treat Parkinson's disease, expects to start earning money from the program sometime in 2019. Intec recently completed enrolling 462 patients for a Phase III trial for the pill that opens up like an accordion, with the levodopa drug remaining in the stomach for 8-12 hours, requiring fewer doses a day. Results are expected in mid-2019.

Encourage teens to discuss relationships, experts say

Healthcare providers and parents should begin talking to adolescents in middle school about healthy romantic and sexual relationships and mutual respect for others, a doctors' group urges. Obstetrician-gynecologists, in particular, should screen their patients routinely for intimate partner violence and sexual coercion and be prepared to discuss it, the Committee on Adolescent Health Care of the American College of Obstetricians and Gynecologists advises.

U.S. companies team up with hospitals to reduce employee maternity costs

General Electric Co and other large companies are trying to chip away at rising childbirth costs for U.S. employees, working directly with hospitals to reduce cesarean sections and related complications. The efforts are in very early stages, with few details on their impact outside of cost savings of a few million dollars so far. But they illustrate yet another path companies are taking to bring down U.S. medical costs by working with doctors and hospitals to set health goals.

Regulators investigate salmonella infections linked to Conagra's cake mixes

U.S. health regulators said on Wednesday they were investigating Conagra Brands Inc's facility that makes cake mixes after a sample of the product that contained Salmonella agbeni matched the strain that had infected five people. Conagra on Monday had recalled four varieties of the cake mix after officials in Oregon found Salmonella agbeni in a box of Duncan Hines Classic White Cake Mix.

Falls from soft furniture are leading cause of toddler injuries

Accidents on sofas and beds are now the leading cause of injury for children aged 4 years and younger in the U.S. and a leading cause of trauma for infants, new research suggests. "Parents, family members and caregivers need to be mindful of the risk of leaving an infant or child unattended on a bed or sofa, regardless of how soft the furniture appears or how far from the edge they place their child," study co-author Dr Viachaslau Bradko told Reuters Health by email.

Sanofi and Regeneron's Dupixent gets more positive feedback from U.S. FDA

The U.S. Food & Drug Administration (FDA) regulator has given more positive feedback on the Dupixent eczema treatment being developed by drugmakers Sanofi and Regeneron, the companies said on Tuesday. Dupixent was launched in the United States in April 2017 for the treatment of moderate-to-severe eczema in adults, and the product is seen as a key sales driver for both companies.

(With inputs from Reuters)

(With inputs from agencies.)